Sponsor pipeline

Italfarmaco clinical trial pipeline

Get alerts when Italfarmaco's trials change

5 active trials 4 recruiting 3 Phase 3 1 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

Active trials by phase

Phase 2
2
Phase 2/3
1
Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT05933057 Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne… Duchenne Muscular Dystrophy Recruiting 2026-07-24
NCT06093672 Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With… Polycythemia Vera Recruiting 2026-03-25
Phase 2/3
NCT03373968 Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study Duchenne Muscular Dystrophy Recruiting 2026-01-21
Phase 2
NCT06769633 Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to… Duchenne Muscular Dystrophy Recruiting 2025-07-10
NCT01761968 Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic… Chronic Myeloproliferative Neoplasms Active, Not Recruiting 2025-04-30

Disease areas by active trials

Duchenne Muscular Dystrophy (3)

Get alerts when Italfarmaco's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free